Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Alendronate is a bisphosphonate used in treating osteoporosis. Its recognized side-effects include oesophageal irritation and ulceration. The authors describe a case of laryngitis induced by transient contact of this medication with the laryngeal mucosa. Successful management of this case is also detailed.

Original publication

DOI

10.1258/0022215053222969

Type

Journal article

Journal

J Laryngol Otol

Publication Date

01/2005

Volume

119

Pages

46 - 47

Keywords

Aged, Alendronate, Female, Humans, Laryngeal Mucosa, Laryngitis, Osteoporosis, Postmenopausal